It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Dr. Eduardo Montana, 55, pleaded guilty in a Boston court hearing to disclosing 280 patients’ “individually identifiable health information”
Aegerion conspired to surreptitiously gather patient data in order to determine their suitability for the product. Juxtapid, which received FDA approval in 2012, is only suitable for use for patients with a rare lipid disorder. However, both defendants willingly targeted patients that did not suffer from the condition. After providing patient data, Montana requested a $236,000 grant from Aegerion, which the company declined.
That side....caveat emptor. DOn't take meds as prescribed without knowing what you are taking, and why. Inform yourself. You don't have to be a doctor to follow some basic chemistry, or to research function.
originally posted by: MindBodySpiritComplex
Ah yes, big pharma and doctors without a moral compass. What could possibly go wrong?
Doctors get rich from controversial drug maker as patients become addicts
originally posted by: bigfatfurrytexan
a reply to: Boadicea
I've no issue finding a new doctor.
My current physician is new for me, and im still training him. I have the benefit of using Baylor's Scott and White system, so there's a never ending supply of good physicians using a good system. Prior, i used a doctor that I was also personal friends with (we moved).